EUVIMEDEUVIMED entdecken
Crossref

Spinal lipocalin 2 as a factor in the development of central post-stroke pain

Kazuo Nakamoto, Shogo Tokuyama

Brain Research · 2024

DOI: 10.1016/j.brainres.2024.148976 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2024. Verfasst von Kazuo Nakamoto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Japan. Hauptthemen laut MEDLINE: Lipocalin-2, Spinal Cord, Stroke, Astrocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Central poststroke pain (CPSP) is a type of central neuropathic pain whose mechanisms remain unknown. Recently, we showed that activated astrocytes and microglial cells are present in the spinal cord of CPSP model mice. Activated glial cells exacerbate cerebral ischemic pathology by increasing the expression of inflammatory factors. However, the involvement of spinal glial cells in CPSP remains unknown. We hypothesized that spinal glial cell-derived molecules cause hyperexcitability or promoted the development of CPSP. In this study, we identified glial cell-derived factors involved in the development of CPSP using a bilateral common carotid occlusion (BCAO)-induced CPSP mouse model. Male ddY mice were subjected to BCAO for 30 min. The von Frey test assessed mechanical hypersensitivity in the right hind paw of mice. BCAO mice showed hypersensitivity to mechanical stimuli and astrocyte activation in the spinal cord 3 days after treatment. DNA microarray analysis revealed a significant increase in lipocalin 2 (LCN2), is known as neutrophil gelatinase-associated lipocalin, in the superficial dorsal horns of BCAO-induced CPSP model mice. LCN2 colocalized with GFAP, an astrocyte marker. Spinal GFAP-positive cells in BCAO mice co-expressed signal transducer and activator of transcription 3 (STAT3). The increase in the fluorescence intensity of LCN2 and GFAP in BCAO mice was suppressed by intrathecal injection of AG490, an inhibitor of JAK2 and downstream STAT3 activation, or anti-LCN2 antibody. Our findings indicated that LCN2 in spinal astrocytes may be a key molecule and may be partly involved in the development of CPSP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipocalin-2Spinal CordStrokeAstrocytesDisease Models, AnimalAnimalsMaleMiceSTAT3 Transcription FactorNeuralgiaJanus Kinase 2TyrphostinsGlial Fibrillary Acidic Protein

Stichwörter der Autor:innen

Bilateral carotid artery occlusionCentral post-stroke painGlial cellLipocalinSpinal cord

Substanzen

Lipocalin-2Lcn2 protein, mouseSTAT3 Transcription FactorStat3 protein, mouseJanus Kinase 2Tyrphostinsalpha-cyano-(3,4-dihydroxy)-N-benzylcinnamideGlial Fibrillary Acidic Protein

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Japan.
  • Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Japan. Electronic address: stoku@pharm.kobegakuin.ac.jp.

Zitieren

APA

Nakamoto, K., & Tokuyama, S. (2024). Spinal lipocalin 2 as a factor in the development of central post-stroke pain. Brain Research. https://doi.org/10.1016/j.brainres.2024.148976

Vancouver

Nakamoto K, Tokuyama S. Spinal lipocalin 2 as a factor in the development of central post-stroke pain. Brain Research. 2024. doi:10.1016/j.brainres.2024.148976

BibTeX
@article{Nakamoto2024,
  author = {Nakamoto, Kazuo and Tokuyama, Shogo},
  title = {Spinal lipocalin 2 as a factor in the development of central post-stroke pain},
  journal = {Brain Research},
  year = {2024},
  doi = {10.1016/j.brainres.2024.148976}
}
Kostenlos starten →